Ritu Kulshreshtha

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 18

Top Venues

Journal of cellular physiology

Dalton transactions (Cambridge, England : 2003)

Cellular and molecular life sciences : CMLS

International journal of cancer

Indian Institute of Technology Delhi

University of Delhi South Campus (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Indian Institute of Technology Delhi Dec 28 2016

India

Associate Professor :: Biochemical Engineering and Biotechnology

Indian Institute of Technology Delhi Feb 01 2010 - Dec 27 2016

India

Assistant Professor :: Biochemical Engineering and Biotechnology

Jawaharlal Nehru University

India

Pool Scientist :: School of Life Sciences

New England Medical Center

United States

Post Doctoral Fellow

Education History

University of Delhi South Campus

India

MSC :: Plant Molecular Biology

University of Delhi South Campus

India

PHD :: Plant Molecular Biology

University of Delhi

India

BSC :: Hansraj College

Publications

Abhijit Saha, Indranil Mondal, Anuj Kumari, Avinash Kumar Sonkar, Ramranjan Mishra, Ritu Kulshreshtha, Ashis K Patra
Hyphenation of lipophilic ruthenium(II)-diphosphine core with 5-fluorouracil: an effective metallodrug against glioblastoma brain cancer cells. Dalton transactions (Cambridge, England : 2003) (2024)
Abhijit Saha, Indranil Mondal, Anuj Kumari, Avinash Kumar Sonkar, Ramranjan Mishra, Ritu Kulshreshtha, Ashis K Patra
Hyphenation of lipophilic ruthenium(II)-diphosphine core with 5-fluorouracil: an effective metallodrug against glioblastoma brain cancer cells. Dalton transactions (Cambridge, England : 2003) 53 (4) (2024)
Vaishali Suri, Omkar Suhas Vinchure, Garima Yadav, Chitra Sarkar, Ritu Kulshreshtha
A novel interplay between PRC2 and miR-3189 regulates epithelial-mesenchymal transition (EMT) via modulating COL6A2 in glioblastoma. Journal of cellular physiology 239 (8) (2024)
Vaishali Suri, Omkar Suhas Vinchure, Garima Yadav, Chitra Sarkar, Ritu Kulshreshtha
A novel interplay between PRC2 and miR-3189 regulates epithelial-mesenchymal transition (EMT) via modulating COL6A2 in glioblastoma. Journal of cellular physiology 239 (8) (2024)
Abhijit Saha, Indranil Mondal, Anuj Kumari, Avinash Kumar Sonkar, Ramranjan Mishra, Ritu Kulshreshtha, Ashis K Patra
Hyphenation of lipophilic ruthenium(II)-diphosphine core with 5-fluorouracil: an effective metallodrug against glioblastoma brain cancer cells. Dalton transactions (Cambridge, England : 2003) 53 (4) (2024)
Vaishali Suri, Omkar Suhas Vinchure, Garima Yadav, Chitra Sarkar, Ritu Kulshreshtha
A novel interplay between PRC2 and miR-3189 regulates epithelial-mesenchymal transition (EMT) via modulating COL6A2 in glioblastoma. Journal of cellular physiology (2024)
Abhijit Saha, Indranil Mondal, Anuj Kumari, Avinash Kumar Sonkar, Ramranjan Mishra, Ritu Kulshreshtha, Ashis K Patra
Hyphenation of lipophilic ruthenium(II)-diphosphine core with 5-fluorouracil: an effective metallodrug against glioblastoma brain cancer cells. Dalton transactions (Cambridge, England : 2003) 53 (4) (2024)
Indranil Mondal, Syeda Warisul Fatima, Swati Priya, Sagar Sengupta, Sunil Kumar Khare, Ritu Kulshreshtha
Transglutaminase-Polyethyleneimine Nanoflowers Mediated Cellular Delivery of Anti-miR-210 for Effective Glioblastoma Therapy. ACS biomaterials science & engineering (2023)
Iman Dandapath, Rahul Gupta, Jyotsna Singh, Nidhi Shukla, Prerana Jha, Vikas Sharma, Ashish Suri, M C Sharma, Vaishali Suri, Chitra Sarkar, Ritu Kulshreshtha
Long Non-coding RNA and mRNA Co-expression Network Reveals Novel Players in Pleomorphic Xanthoastrocytoma. Molecular neurobiology 59 (8) (2022)
Srishti Srivastava, Hima Makala, Vikas Sharma, Vaishali Suri, Chitra Sarkar, Ritu Kulshreshtha
MED12 is overexpressed in glioblastoma patients and serves as an oncogene by targeting the VDR/BCL6/p53 axis. Cellular and molecular life sciences : CMLS 79 (2) (2022)
Sonam Takkar, Vikas Sharma, Sourabh Ghosh, Ashish Suri, Chitra Sarkar, Ritu Kulshreshtha
Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS. Cellular oncology (Dordrecht) 44 (2) (2021)
Garima Yadav, Ritu Kulshreshtha
Metastasis associated long noncoding RNAs in glioblastoma: Biomarkers and therapeutic targets. Journal of cellular physiology (2021)
Omkar Suhas Vinchure, Kurt Whittemore, Deependra Kushwah, Maria A Blasco, Ritu Kulshreshtha
miR-490 suppresses telomere maintenance program and associated hallmarks in glioblastoma. Cellular and molecular life sciences : CMLS 78 (5) (2020)
Anubha Shukla, Srishti Srivastava, Jayant Darokar, Ritu Kulshreshtha
HIF1α and p53 Regulated MED30, a Mediator Complex Subunit, is Involved in Regulation of Glioblastoma Pathogenesis and Temozolomide Resistance. Cellular and molecular neurobiology 41 (7) (2020)
Srishti Srivastava, Ritu Kulshreshtha
Insights into the regulatory role and clinical relevance of mediator subunit, MED12, in human diseases. Journal of cellular physiology 236 (5) (2020)
Omkar Suhas Vinchure, Ritu Kulshreshtha
miR-490: A potential biomarker and therapeutic target in cancer and other diseases. Journal of cellular physiology 236 (5) (2020)
Omkar S Vinchure, Vikas Sharma, Saba Tabasum, Sourabh Ghosh, Rana P Singh, Chitra Sarkar, Ritu Kulshreshtha
Polycomb complex mediated epigenetic reprogramming alters TGF-β signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas. International journal of cancer 145 (5) (2019)
Rahul Agrawal, Ankita Garg, Prit Benny Malgulwar, Vikas Sharma, Chitra Sarkar, Ritu Kulshreshtha
p53 and miR-210 regulated NeuroD2, a neuronal basic helix-loop-helix transcription factor, is downregulated in glioblastoma patients and functions as a tumor suppressor under hypoxic microenvironment. International journal of cancer 142 (9) (2017)

Ritu Kulshreshtha.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ritu Kulshreshtha